Hims & Hers Health Inc. (HIMS)
HIMS trades on NYSE in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1773751/000177375126000022/0001773751-26-000022-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | HIMS on NYSE |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2019 |
| SEC CIK | 0001773751 |
| SEC industry code | Services-Offices & Clinics of Doctors of Medicine |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.3B |
| Net income | $128.4M |
| Operating income | $105.6M |
| Net margin | 5.5% |
| Operating margin | 4.5% |
| Revenue growth | +59.0% |
| Cash | $228.6M |
| Total assets | $2.2B |
| P/E (computed) | 33.9× |
| P/S (computed) | 1.9× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-09 |
| Cash and burn | $605.6M cash; operating cash flow $45.0M a quarter. | Report 2026-09-30 |
| Shares outstanding | 234,412,422 (2026-11-06); 227,648,514 a year earlier. | Cover page 2026-11-06 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | KPMG LLP, San Francisco, California, United States | PCAOB Form AP 2026-03-24 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $1.2M, sold $31.7M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $890.4M | -$33.0M | $65.4M | $605.6M | $1.4B | $2.9B | 10-Q 2026-11-09 |
| Q2 2026 2026-06-30 | $753.2M | -$86.3M | -$35.9M | $609.8M | $1.4B | $2.6B | 10-Q 2026-08-10 |
| Q1 2026 2026-03-31 | $608.1M | -$92.1M | $89.4M | $222.3M | $974.1M | $2.4B | 10-Q 2026-05-11 |
| Q4 2025 2025-12-31 | $617.8M | $20.6M | $61.3M | $228.6M | $972.6M | $2.3B | 10-K 2026-02-23 |
| Q3 2025 2025-09-30 | $599.0M | $15.8M | $148.7M | $345.8M | $971.0M | $2.2B | 10-Q 2026-11-09 |
| Q2 2025 2025-06-30 | $544.8M | $42.5M | -$19.1M | $1.1B | $969.5M | $2.0B | 10-Q 2026-08-10 |
| Q1 2025 2025-03-31 | $586.0M | $49.5M | $109.1M | $273.7M | No debt tags | $1.8B | 10-Q 2026-05-11 |
| Q4 2024 2024-12-31 | $481.1M | $26.0M | $86.4M | $220.6M | $0 | $1.5B | 10-K 2026-02-23 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B7 | 2024-09-09 |
| Latest annual report | 10-K | 2026-02-23 |
| Latest quarterly / interim | 10-Q | 2026-11-09 |
| Latest current report | 8-K | 2026-11-09 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 1,007 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -24.1% |
| 1 month | -33.6% |
| 3 months | -31.4% |
| Year to date | -39.2% |
| 1 year | -45.3% |
| From 52-week high | -50.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OPCH | Option Care Health Inc. | $31.71 | +0.19% | $4.8B |
| LFST | LifeStance Health Group Inc. | $14.48 | +2.84% | $5.5B |
| PRVA | Privia Health Group Inc. | $25.26 | +2.89% | $3.2B |
| CHE | Chemed Corp | $549.45 | +0.36% | $7.2B |
| AVAH | Aveanna Healthcare Holdings Inc. | $11.63 | +1.13% | $2.5B |
| ADUS | Addus HomeCare Corporation | $124.61 | +1.31% | $2.3B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
| WGS | GeneDx Holdings Corp. | $51.02 | -2.58% | $1.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier